A new study shows NAC antioxidant therapy bypasses 22q11.2 deletion syndrome deficits via alternative gene networks.

Antibodies are pivotal in immunology, driving advancements in precision medicine with monoclonal antibodies, ADCs, and ...

Texxecure has launched a standardized rating system for photovoltaic projects, assessing technical risks from components and ...

Scientists have advanced the field of cancer treatment by leveraging the body’s immune system to recognize and target tumors.

The European Union is on the cusp of giving the green light to a digital euro. Opponents worry the new CBDC could quickly ...

German defence manufacturer Diehl Defence is developing a long-range variant of its IRIS-T air-defence system that could help ease reliance on the US-made Patriot missile system, whose interceptors ...

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

CTx001, a gene therapy for geographic atrophy, received FDA Fast Track Designation, expediting its development and review process. The Opti-GAIN phase 1/2 trial will assess CTx001's safety, ...

SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, today announced positive ...

Similar to the numeric system in place in Europe and Australia, Equibase Ratings could be used as early as Oct. 24 at Santa Anita The subject of an alternative to claiming races was first raised at ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...